Pan Ognian Donew jest Prezesem Rady Dyrektorskiej oraz Dyrektor wykonawczy zakładu farmaceutycznego Sopharma S.A.. Prezes Międzynarodowej Izby Handlowej ze strony Republiki Bułgarii, tak samo Prezes Rady Społecznej przy Akademii Medycznej w Sofii. Wydawca mediów pt. "Club Z". 

Sopharma AD (the “Company”) hereby notifies that on 14 December 2016 Sopharma AD filed with the Financial Supervision Commission a tender offering for the shares of all other shareholders in Unipharm AD.

Sopharma AD as a offeree states that it does not own 1 342 234 shares, representing 22.37% from the total number of sahres with ISIN BG1100154076 and from the votes in the general meeting of Unipharm AD and files the tender offering to the remaining sahreholders owning ordinary shares of Unipharma AD for the purchase of those shares. 

For the first eleven months of this year, revenues from sales decreased by 5% compared to the same period of 2015, including 2% increase of domestic sales and 10% decrease of export sales. “The Russian market remains uncertain, which does not allow us to make forecasts for the year-end sales results, but we managed to limit the decrease of sales revenues in the second half of 2016.”, states Ognian Donev, PhD, Executive Director and Chairman of the Board of Directors of Sopharma AD.